Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2023
DOI: 10.1007/s00395-022-00972-1
|View full text |Cite
|
Sign up to set email alerts
|

Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 193 publications
0
6
0
Order By: Relevance
“…These independent or combined "single" technologies have helped us not only to create a high-resolution SC type map of human tissues [127] and three-dimensional nuclear architecture, gene expression, and epigenetic modifications, [128] but also to assess and analyze immune cell differentiation, [129,130] to uncover cellular and molecular mechanisms and to discover new therapeutic targets for human diseases, [49,[131][132][133] in particular COVID-19 and CVDs, as well as to trace cancer progression. [134] It can be said that this is indeed a new "single" era of biomedicine and its current implications and research in both CVDs and COVID-19 [135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150] as well as others will definitely open a new beautiful future.…”
Section: Cavdmentioning
confidence: 99%
“…These independent or combined "single" technologies have helped us not only to create a high-resolution SC type map of human tissues [127] and three-dimensional nuclear architecture, gene expression, and epigenetic modifications, [128] but also to assess and analyze immune cell differentiation, [129,130] to uncover cellular and molecular mechanisms and to discover new therapeutic targets for human diseases, [49,[131][132][133] in particular COVID-19 and CVDs, as well as to trace cancer progression. [134] It can be said that this is indeed a new "single" era of biomedicine and its current implications and research in both CVDs and COVID-19 [135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150] as well as others will definitely open a new beautiful future.…”
Section: Cavdmentioning
confidence: 99%
“…Single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (RNA-seq) have emerged as essential techniques for exploring cellular heterogeneity, differentiation, and disease mechanisms [1][2][3][4][5][6] . These technologies facilitate numerous applications, including the conversion of bulk-seq data into single-seq analyses 7 , performing differential expression analysis 8 , pathway enrichment 9 , gene co-expression network analysis in bulk RNA-seq 10 , cell annotation 11 , cell interaction analysis 12 , celltrajectory inference 13 , evaluation of cell-state in gene sets, and prediction of drug response in scRNA-seq 14 .…”
Section: Mainmentioning
confidence: 99%
“…Moreover, based on the differentially expressed genes of the cluster, activated pathways can be statistically determined using specific algorithms, such as gene set enrichment analysis (GSEA) (19). A growing number of studies implement scRNA-seq to accelerate the understanding of different disorders (20)(21)(22). Furthermore, it also facilitates drug development and transition from the bench to the bedside (20,21).…”
Section: Introductionmentioning
confidence: 99%
“…A growing number of studies implement scRNA-seq to accelerate the understanding of different disorders (20)(21)(22). Furthermore, it also facilitates drug development and transition from the bench to the bedside (20,21). In this study, we have delved into the transcriptomic landscape of immune cells in sepsis through scRNA-seq analysis.…”
Section: Introductionmentioning
confidence: 99%